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Extended FAM sample description 
We included 395 members of 33 families in the present analyses. 166 
participants were diagnosed with BD (BD type I (BD-I), n=115; BD type II (BD-
II), n=41; not otherwise specified (NOS) BD, n=10), 78 with MDD (recurrent 
MDD (R-MDD), n=53; single episode MDD (SE-MDD), n=17; NOS MDD, n=8), 
and 151 without a history of an affective disorder. 
Diagnoses were assigned by two trained clinicians according to DSM IV using 
the best estimate approach. Diagnosis and clinical data were based on the 
Schedule for Affective Disorders and Schizophrenia (SADS)1, the Operational 
Criteria Checklist for Psychotic and Affective Illness (OPCRIT)2, the Family 
Informant Schedule and Criteria (FISC)3, and on clinical records. 
A severe impairment during the disorder (see Table 1) corresponded to a level 
of 3 in the OPCRIT item 87 (no function at all in a major life role for more than 
two days or in-patient treatment has been required or active psychotic 
symptoms such as delusions or hallucinations have occurred). 
 
Quality control (QC) 
QC of genotype data was conducted in PLINK v1.90b3.36. QC was carried out 
first on each of both cohorts separately (FAM and CC), followed by a second 
round of QC on the combined dataset. 
Sequence of QC steps: 
1. FAM (genotyped on Infinium PsychArray BeadChip (PsychChip)) 
Before QC: 395 individuals and 588,454 variants 
1.1. Removal of SNPs with call rates <98% or a MAF <1% 
1.2. Check for individuals with genotyping rates <98% (none removed) 
1.3. Check for sex mismatches (none removed) 
1.4. Removal of non-autosomal variants 
1.5. Removal of SNPs with call rates <98%, a MAF <1%, or Hardy-
Weinberg Equilibrium (HWE) test p-values <1×10-6  
1.6. Removal of A/T and G/C SNPs 
1.7. Update of variant IDs and positions to the IDs and positions in the 1000 
Genomes Phase 3 reference panel 
1.8. Alignment of alleles to the reference panel 
1.9. Removal of duplicated variants and of variants not present in the 
reference panel 






2. CC (Illumina HumanOmni1-Quad and Illumina Human610-Quad, combined 
and quality-controlled as previously published4; the QC described here was 
conducted on the published data) 
Before QC: 547 individuals and 333,353 variants 
2.1. Removal of SNPs with call rates <98% or a MAF <1% 
2.2. Check for individuals with genotyping rates <98% (none removed) 
2.3. Check for sex mismatches (none removed) 
2.4. Check for genetic duplicates (none removed) 
2.5. Removal of individuals where the autosomal or X-chromosomal 
heterozygosity deviated from the mean >4 SD (six removed) 
2.6. Removal of non-autosomal variants 
2.7. Removal of SNPs with call rates <98%, a MAF <1%, or HWE test 
p-values <1×10-6 
2.8. Removal of A/T and G/C SNPs 
2.9. Update of variant IDs and positions to the IDs and positions in the 1000 
Genomes Phase 3 reference panel 
2.10. Alignment of alleles to the reference panel 
2.11. Removal of duplicated variants and variants not present in the 
reference panel 
After QC: 541 individuals and 315,634 variants  
 
3. Combined dataset of both samples (936 individuals and 116,079 variants) 
3.1. Removal of SNPs with call rates <98% or a MAF <1% 
3.2. Removal of individuals with genotyping rates <98% (two removed) 
3.3. Removal of individuals duplicated between both datasets (31 removed 
from the CC sample) 
3.4. Removal of genetic outliers with a distance from the mean of >4 SD in 
the first eight MDS components (15 removed from the CC sample) 
3.5. Removal of individuals where the autosomal heterozygosity deviated 
from the mean >4 SD (eleven removed from the FAM sample) 
3.6. Removal of SNPs with call rates <98%, a MAF <1%, or HWE test 
p-values <1×10-6 
3.7. Removal of individuals from the CC sample that have been recruited as 
part of the FAM/ABiF cohort (55 removed) 
After QC: 822 individuals (384 FAM and 438 CC) and 116,067 variants  
 
Population substructure analysis 
For the population substructure analyses, pre-imputation genotype data was 
used, after the QC steps explained above had been applied. Additional variant 
filtering steps were: removal of variants with a MAF <0.05 or HWE p-value 
<10-3; removal of variants mapping to the extended MHC region (chromosome 
6, 25-35 Mbp) or to a typical inversion site on chromosome 8 (7-13 Mbp); LD 
pruning (command --indep-pairwise 200 100 0.2).  
Next, the pairwise identity-by-state (IBS) matrix of all individuals was calculated 
using the command --genome on the filtered genotype data. Multidimensional 
scaling (MDS) analysis was performed on the IBS matrix using the 




In an MDS analysis, the high relatedness between family members leads to 
artifacts. To avoid such artifacts, only one person per family was included in 
population substructure analyses. For each of the 33 families, the individual with 
the highest absolute values in MDS components 1 and 2 was selected to 
represent the respective family. Afterwards, the MDS analysis was repeated, 
using only selected individuals from the FAM sample. 
Whether MDS components differ between cohorts was analyzed with logistic 
regression using the following model without additional covariates:  
cohort (FAM/CC) ~ MDS components. 
The ten calculated MDS components showed association p-values with cohort 
≥0.30, except for component 3, which was associated with cohort at nominal 
significance with p=0.036. After correction for multiple testing (ten 
comparisons), this difference observed for component 3 was not significant. 
 
Imputation of genotype data 
Genotypes were aligned to the 1000 Genomes Phase 3 reference panel using 
SHAPEIT v2 (r837) and PLINK v1.90b3.36. Pre-phasing (haplotype estimation) 
was conducted for each chromosome separately using SHAPEIT with the  
--duohmm option. Imputation was performed using IMPUTE2 v2.3.2 in 5 Mbp 
chunks with 500 kbp buffers, filtering out variants that are monomorphic in the 
EUR samples. Chunks with <51 genotyped variants or concordance rates <92 
% were fused with neighboring chunks and re-imputed. Imputed variants with a 
MAF 1% or an INFO metric 0.8 were removed.  
Imputed variants in the combined sample after QC: 6,862,461 
Imputed variants in the FAM sample after QC: 8,628,089 
Note that optimized imputation algorithms for pedigrees exist, for example, 
GIGI5. GIGI mainly improves imputation accuracy of rare variants but does not 
have a clear advantage over population-based methods regarding common 
variants. Moreover, GIGI can only impute one pedigree at a time and cannot 
impute unrelated individuals. As we were only interested in common variation 
(MAF ≥1%) and also wanted to analyse a mixed sample of related and 
unrelated subjects, we chose a population-based imputation method using 






Generation and analysis of PRS 
The GWAS test statistics and imputed variants in our data were merged based 
on chromosome, position, and alleles of each variant. Summary statistics were 
then clumped in PLINK v1.90b5.2, based on best-guess genotype data (hard-
call threshold 0.3) using the following parameters:  
--clump-kb 500 --clump-r2 0.1 --clump-p1 1 --clump-p2 1 
PRS were then calculated in R v.3.3 based on imputed (dosage) data. Test 
statistics and alleles in the GWAS training data were flipped so that effect sizes 
were always positive. Thus, the weighted PRS represent cumulative, additive 
risk. PRS were scaled to represent the relative risk load (minimum possible 
cumulative risk load = 0, maximum = 1). For each disorder, ten PRS with 
different p-value thresholds were calculated: <5×10-8, <1×10-7, <1×10-6, 
<1×10-5, <1×10-4, <0.001, <0.01, <0.05, <0.1, <0.2. 
The analyses of linear mixed models using GenABEL were conducted in the 
following manner: In the first step of the PRS analyses, residuals were 
calculated with the GenABEL polygenic function using the formula phenotype ~ 
covariates (where the phenotype corresponded to the diagnosis/cohort groups 
contrasted in a given analysis), including the genetic relationship matrix as a 
random effect. Residuals from this model were then used in a second linear 
model with the formula residuals ~ PRS. Test statistics including 95% CI were 
calculated using bootstrapping (R package boot, nonparametric bootstrapping 
using ordinary resampling with 2,000 replications). 
 
Data availability 
GWAS summary statistics for PRS calculation can be obtained from the following 
sources: 
PGC BD, MDD, and SCZ GWAS from the Psychiatric Genomics Consortium: 
https://www.med.unc.edu/pgc/results-and-downloads/ 
From these summary statistics, the Shared and the simulated PRS can be calculated 
following the R scripts available at: 
https://gitlab.com/tillandlauer/abif-prs-analyses/ 
The GWIS PRS can be calculated following this example: 
https://sites.google.com/site/mgnivard/gwis/code-example-decompose-2-traits 
The IGAP LOAD GWAS results can be obtained from IGAP: 
http://web.pasteur-lille.fr/en/recherche/u744/igap/igap_download.php 
For genotype and phenotype data of the CC sample, please contact the corresponding 
authors of the following study: 
Mühleisen TW, Leber M, Schulze TG, Strohmaier J, Degenhardt F, Treutlein J et al. 
Genome-wide association study reveals two new risk loci for bipolar disorder. Nature 
Communations 2014; 5:3339. 
For genotype and phenotype data of the ABiF sample, please contact the 






FAMMDD cases had significantly higher BD and MDD than CCcontrols. The SCZ, 
Shared, and SCZ-MDD GWIS PRS were increased at nominal significance only 
in FAMMDD. This may be due to the lower genetic correlation of MDD and SCZ 
compared to the correlation of BD and SCZ7-10. However, when interpreting the 
results for FAMMDD cases, it is important to consider that much fewer MDD than 
BD cases have been analysed (Table 1). The power of MDD-based analyses in 
the present study was thus considerably lower than for BD. This lower statistical 
power is also a possible explanation for why FAMMDD cases only showed a 
nominally increased MDD PRS over FAMunaffected individuals. In addition to 
suggesting a cross-disorder illness burden, the increased BD PRS in FAMMDD 
cases may also indicate that, in some cases, the current MDD diagnosis 
constituted a prodromal stage of BD11. Furthermore, in ABiF families, MDD may 
be more strongly driven by BD risk variants and therefore have closer etiological 
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Supplementary Fig. S1: Boxplots of PRS at different p-value thresholds for CCcontrols, 
FAMunaffected, and BD cases. FAM samples excluded from the analyses of the combined 
dataset are not shown in these plots, i.e., family members with a history of substance 
abuse, married-in family members, or family members diagnosed with MDD. CC = 
Case/control sample. 
Supplementary Fig. S1A: Boxplots of BD PRS.  
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Supplementary Fig. S1C: Boxplots of MDD PRS. 
 
Supplementary Fig. S1D: Boxplots of the BD+SCZ+MDD Shared PRS. Note that 
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Supplementary Fig. S1E: Boxplots of the BD-SCZ GWIS PRS. 
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Supplementary Fig. S1G: Boxplots of the SCZ-BD GWIS PRS. 
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Supplementary Fig. S1I: Boxplots of the LOAD (Alzheimer) PRS. 
 
 
Supplementary Fig. S2: Association analysis comparing PRS in FAMBD cases and 
CCcontrols. Further details of the plots are described in the legend for Fig. 1. Full 
association test statistics including p-values are shown in Supplementary Table S3. 
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Supplementary Fig. S2B: Association of the SCZ PRS. 
 
 


















































































































































Supplementary Fig. S2D: Association of the Shared PRS. 
 
 















































































































































Supplementary Fig. S2F: Association of the BD-MDD GWIS PRS. 
 
 


















































































































































Supplementary Fig. S2H: Association of the MDD-BD GWIS PRS. 
 
 


















































































































































Supplementary Fig. S3: Association analysis comparing PRS in FAMBD cases and 
unrelated CCBD cases. Further details of the plots are given in the legend for Fig. 1. Full 
association test statistics including p-values are shown in Supplementary Table S4. 
Supplementary Fig. S3A: Association of the BD PRS (data is identical to Fig. 1C). 
 
 

















































































































































Supplementary Fig. S3C: Association of the MDD PRS. 
 
 















































































































































Supplementary Fig. S3E: Association of the BD-SCZ GWIS PRS. 
 
 

















































































































































Supplementary Fig. S3G: Association of the SCZ-BD GWIS PRS. 
 
 


















































































































































Supplementary Fig. S3I: Association of the LOAD PRS. 
 
Supplementary Fig. S4: Association analysis comparing PRS in FAMunaffected and 
CCcontrols. Further details of the plots are described in the legend for Fig. 1. Full 
association test statistics including p-values are shown in Supplementary Table S5. 


















































































































































Supplementary Fig. S4B: Association of the SCZ PRS. 
 
 


















































































































































Supplementary Fig. S4D: Association of the Shared PRS. 
 
 














































































































































Supplementary Fig. S4F: Association of the BD-MDD GWIS PRS. 
 
 


















































































































































Supplementary Fig. S4H: Association of the MDD-BD GWIS PRS. 
 
 



















































































































































Supplementary Fig. S5: Association analysis comparing PRS in FAMBD cases and 
FAMunaffected. Further details of the plots are given in the legends for Figs. 1 and 2. Full 
association test statistics including p-values are shown in Supplementary Table S6. 
Supplementary Fig. S5A: Association of the BD PRS (data is identical to Fig. 2A). 
 
 




















































































































































Supplementary Fig. S5C: Association of the MDD PRS. 
 
 















































































































































Supplementary Fig. S5E: Association of the BD-SCZ GWIS PRS. 
 
 



















































































































































Supplementary Fig. S5G: Association of the SCZ-BD GWIS PRS. 
 
 


















































































































































Supplementary Fig. S5I: Association of the LOAD PRS. 
 
  









































































Supplementary Fig. S6: Analysis of assortative mating. Further details regarding the 
analysis and plots are described in the legend for Fig. 2C. Full association test 
statistics including p-values are shown in Supplementary Table S7. Significance 
threshold: α=0.05/20=0.0025. 
Supplementary Fig. S6A: Association analysis comparing the BD PRS in unaffected 
married-in family members and CCcontrols. 
 
Supplementary Fig. S6B: Association analysis comparing the BD PRS in unaffected 























































































































































Supplementary Fig. S7: Analysis of anticipation in the FAM sample. Further details 
regarding the analysis and plots are described in the legend for Fig. 2D. Full 
association test statistics including p-values are shown in Supplementary Table S8. 
Supplementary Fig. S7A: Association of the BD PRS with generation. 
 
Supplementary Fig. S7B: Association analysis comparing the age at onset for BD 
across generations. The age at onset did not decrease over generations (p=0.54, 
Supplementary Table S8). Covariates were sex and age. One-sided p-values were 
calculated, following the hypothesis that the age at onset decreases across 

































































































































































Supplementary Fig. S8: Boxplots of PRS at different p-value thresholds, including 
FAMMDD cases. The following individuals are not shown in these plots: Family members 
with a history of substance abuse, married-in family members, and CCBD cases. 
Supplementary Fig. S8A: Boxplots of BD PRS. 
 













































0.001 0.01 0.05 0.1 0.2






























































































































0.001 0.01 0.05 0.1 0.2































































Supplementary Fig. S8C: Boxplots of MDD PRS. 
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Supplementary Fig. S8E: Boxplots of the MDD-BD GWIS PRS. 
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Supplementary Fig. S8G: Boxplots of the BD-MDD GWIS PRS. 
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Supplementary Fig. S8I: Boxplots of the SCZ-BD GWIS PRS. 
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Supplementary Fig. S9: Association analysis comparing PRS in FAMMDD cases and 
CCcontrols. Further details of the plots are described in the legend for Fig. 1. Full 
association test statistics including p-values are shown in Supplementary Table S9. 
Supplementary Fig. S9A: Top-associated p-value thresholds for the tested PRS. The 
column to the left shows PRS and pPRS thresholds. 
 
 


















































































Supplementary Fig. S9C: Association of the SCZ PRS. 
 
 






























































































































































Supplementary Fig. S9E: Association of the Shared PRS. 
 



























































































































































Supplementary Fig. S9G: Association of the MDD-SCZ GWIS PRS. 
 
 






























































































































































Supplementary Fig. S9I: Association of the SCZ-MDD GWIS PRS. 
 
 






























































































































































Supplementary Fig. S9K: Association of the LOAD PRS. 
 
Supplementary Fig. S10: Association analysis comparing PRS in FAMMDD cases and 
FAMunaffected. Further details of the plots are given in the legends for Figs. 1 and 2. Full 
association test statistics including p-values are shown in Supplementary Table S10. 
Supplementary Fig. S10A: Top-associated pPRS thresholds for the tested PRS. The 


















































































Supplementary Fig. S10B: Association of the BD PRS (all p-value thresholds). 
 
 

























































































































































Supplementary Fig. S10D: Association of the MDD PRS. 
 
 





















































































































































Supplementary Fig. S10F: Association of the MDD-BD GWIS PRS. 
 
 

























































































































































Supplementary Fig. S10H: Association of the BD-MDD GWIS PRS. 
 
 





























































































































































Supplementary Fig. S10J: Association of the SCZ-BD GWIS PRS. 
 


























































































































































Supplementary Fig. S11: Population substructure analysis. Details regarding the 
generation of MDS components and the population substructure analysis are described 







Supplementary Fig. S12: Association analysis comparing BD PRS in unrelated CCBD 
cases and CCcontrols. Details of the plot are described in the legend for Fig. 1. Covariate 
used: Sex. Full association test statistics including p-values are shown in 









































































IGAP Supplementary Methods and Acknowledgments 
 
IGAP Methods for the LOAD GWAS 
International Genomics of Alzheimer's Project (IGAP) is a large two-stage study based 
upon genome-wide association studies (GWAS) on individuals of European ancestry. 
In stage 1, IGAP used genotyped and imputed data on 7,055,881 single nucleotide 
polymorphisms (SNPs) to meta-analyze four previously-published GWAS datasets 
consisting of 17,008 Alzheimer's disease cases and 37,154 controls (The European 
Alzheimer's disease Initiative – EADI, The Alzheimer Disease Genetics Consortium – 
ADGC, The Cohorts for Heart and Aging Research in Genomic Epidemiology 
consortium – CHARGE, The Genetic and Environmental Risk in AD consortium – 
GERAD). In stage 2, 11,632 SNPs were genotyped and tested for association in an 
independent set of 8,572 Alzheimer's disease cases and 11,312 controls. Finally, a 
meta-analysis was performed combining results from stages 1 & 2. 
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